AI assistant
Sending…
MADRIGAL PHARMACEUTICALS, INC. — Director's Dealing 2018
Jun 13, 2018
30608_dirs_2018-06-13_8801e05f-2cc3-4277-8881-390659bc9d26.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK: 0001157601
Period of Report: 2018-06-11
Reporting Person: Schneebaum Marc R (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-11 | Common Stock | M | 5223 | $99.75 | Acquired | 49033 | Direct |
| 2018-06-11 | Common Stock | M | 2734 | $61.60 | Acquired | 51767 | Direct |
| 2018-06-11 | Common Stock | S | 10099 | $287.46 | Disposed | 41668 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-06-11 | Stock Option | $99.75 | M | 5223 | Disposed | 2024-12-08 | Common Stock (5223) | Direct |
| 2018-06-11 | Stock Option | $61.60 | M | 2734 | Disposed | 2025-10-02 | Common Stock (2734) | Direct |
More from MADRIGAL PHARMACEUTICALS, INC.
Interim / Quarterly Report
2026
May 6
Earnings Release
2026
May 6
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 24
Annual Report
2026
Feb 19
Earnings Release
2026
Feb 19
Regulatory Filings
2026
Jan 30
Director's Dealing
2026
Jan 26